NeueHealth, Inc.
NEUE
$6.73
$0.010.15%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 260.93M | 257.73M | 246.32M | 231.97M | 219.86M |
| Total Other Revenue | 675.73M | 739.16M | 787.04M | 873.37M | 940.94M |
| Total Revenue | 936.66M | 996.89M | 1.03B | 1.11B | 1.16B |
| Cost of Revenue | 742.14M | 822.11M | 865.86M | 933.34M | 996.58M |
| Gross Profit | 194.52M | 174.78M | 167.50M | 172.01M | 164.22M |
| SG&A Expenses | 270.71M | 270.62M | 301.50M | 301.55M | 314.25M |
| Depreciation & Amortization | 15.65M | 16.07M | 16.68M | 17.38M | 18.30M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.03B | 1.11B | 1.18B | 1.25B | 1.33B |
| Operating Income | -91.84M | -111.91M | -150.68M | -146.91M | -168.32M |
| Income Before Tax | -99.46M | -117.55M | -577.02M | -570.16M | -629.17M |
| Income Tax Expenses | 2.60M | 4.86M | -1.32M | -2.02M | -1.43M |
| Earnings from Continuing Operations | -102.06 | -122.41 | -575.70 | -568.14 | -627.74 |
| Earnings from Discontinued Operations | 2.34M | -440.41M | -493.89M | -532.39M | -638.07M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -34.96M | 201.14M | 131.44M | 108.17M | 114.35M |
| Net Income | -134.68M | -361.67M | -938.16M | -992.36M | -1.15B |
| EBIT | -91.84M | -111.91M | -150.68M | -146.91M | -168.32M |
| EBITDA | -76.20M | -89.98M | -128.13M | -123.67M | -144.15M |
| EPS Basic | -22.63 | -51.16 | -123.67 | -130.72 | -150.87 |
| Normalized Basic EPS | -12.95 | 14.91 | 1.89 | -1.39 | -2.93 |
| EPS Diluted | -22.63 | -51.16 | -123.67 | -130.72 | -150.87 |
| Normalized Diluted EPS | -12.95 | 14.91 | 1.89 | -1.39 | -2.93 |
| Average Basic Shares Outstanding | 32.84M | 32.57M | 32.26M | 31.97M | 31.79M |
| Average Diluted Shares Outstanding | 32.84M | 32.57M | 32.26M | 31.97M | 31.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |